Association supports continued amalgam regulation and research
“The panel recommended continuing review of existing and new scientific information as it becomes available,” said Dr. Raymond F. Gist, president of the American Dental Association. “As a science-based organization representing a science-based profession, we support this.” The dental products panel Dec. 15 concluded two days of public hearings on FDA’s regulation of dental amalgam as a medical device.
“As with all clinical issues, our position on amalgam is based on the best available science,” Dr. Gist said. “We will continue to maintain or revise our positions on oral health and oral health care issues accordingly. At the end of the day, all treatment decisions should be made by patients with the advice of their dentists. We support the rights of all patients to decide how best to maintain and improve their oral health.”